OTCMKTS:CRXLY - Crucell Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Crucell (OTCMKTS:CRXLY)

Crucell NV is a Netherlands-based biopharmaceutical company. The Company is focused on developing, producing and marketing products that combat infectious diseases. The Company's product candidates include flu-mAb, an antibody product effective against a range of influenza virus strains, tuberculosis and malaria vaccines, as well as a rabies monoclonal antibody combination, all produced on its PER.C6 human cell-line technology. It focuses on the paediatric, travel and endemic, and respiratory fields. Its core product portfolio includes Quinvaxem, a liquid pentavalent vaccine against five important childhood diseases; Hepavax-Gene, a hepatitis B vaccine; Epaxal, an aluminum-free hepatitis A vaccine; Vivotif and Dukoral, oral vaccines against typhoid and cholera; and Inflexal V, a virosomal adjuvanted vaccine against influenza. It has offices in the Netherlands, China, Indonesia, Italy, Korea, Malaysia, Spain, Sweden, Switzerland, the United Kingdom, the United States and Vietnam.

Receive CRXLY News and Ratings via Email

Sign-up to receive the latest news and ratings for CRXLY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:CRXLY
CUSIPN/A
WebN/A
Phone+31-71-5199100

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Crucell (OTCMKTS:CRXLY) Frequently Asked Questions

What is Crucell's stock symbol?

Crucell trades on the OTCMKTS under the ticker symbol "CRXLY."

Who are some of Crucell's key competitors?

Has Crucell been receiving favorable news coverage?

News articles about CRXLY stock have been trending somewhat positive on Sunday, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Crucell earned a coverage optimism score of 0.22 on Accern's scale. They also assigned headlines about the biopharmaceutical company an impact score of 47.86 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Crucell?

Shares of CRXLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Crucell?

Crucell's mailing address is Archimedesweg 4, LEIDEN, 2333CN, Netherlands. The biopharmaceutical company can be reached via phone at +31-71-5199100.


MarketBeat Community Rating for Crucell (CRXLY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  51
MarketBeat's community ratings are surveys of what our community members think about Crucell and other stocks. Vote "Outperform" if you believe CRXLY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRXLY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Crucell (OTCMKTS:CRXLY) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/22/2016 forward)

Earnings

Crucell (OTCMKTS:CRXLY) Earnings History and Estimates Chart

Earnings by Quarter for Crucell (OTCMKTS:CRXLY)

Crucell (OTCMKTS CRXLY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2011Q4 2010($0.10)($0.12)ViewN/AView Earnings Details
11/9/2010Q3 2010$0.18($0.43)ViewN/AView Earnings Details
8/17/2010Q2 2010$0.13$0.14ViewN/AView Earnings Details
2/9/2010Q4 2009$0.23$0.26ViewN/AView Earnings Details
11/3/2009Q3 2009$0.20$0.22ViewN/AView Earnings Details
8/11/2009Q2 2009$0.06($0.04)ViewN/AView Earnings Details
2/5/2009Q4 2008$0.08$0.38ViewN/AView Earnings Details
11/11/2008Q3 2008$0.09$0.29ViewN/AView Earnings Details
8/12/2008Q2 2008($0.22)($0.19)ViewN/AView Earnings Details
5/13/2008Q1 2008($0.23)($0.21)ViewN/AView Earnings Details
2/12/2008Q4 2007($0.03)($0.10)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Crucell (OTCMKTS:CRXLY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Crucell (OTCMKTS CRXLY) Insider Trading and Institutional Ownership History

Insider Trading History for Crucell (OTCMKTS:CRXLY)

Crucell (OTCMKTS CRXLY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Crucell (OTCMKTS CRXLY) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Crucell (OTCMKTS:CRXLY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Crucell (OTCMKTS CRXLY) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.